{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T20:29:08Z","timestamp":1777062548669,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12967-014-0342-7","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T18:49:04Z","timestamp":1418150944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy"],"prefix":"10.1186","volume":"12","author":[{"given":"Duane","family":"Moogk","sequence":"first","affiliation":[]},{"given":"Ines Pires","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Michelle W","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Erica B","family":"Friedman","sequence":"additional","affiliation":[]},{"given":"Eleazar Vega-Saenz","family":"de Miera","sequence":"additional","affiliation":[]},{"given":"Farbod","family":"Darvishian","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Scanlon","sequence":"additional","affiliation":[]},{"given":"Arianne","family":"Perez-Garcia","sequence":"additional","affiliation":[]},{"given":"Anna C","family":"Pavlick","sequence":"additional","affiliation":[]},{"given":"Nina","family":"Bhardwaj","sequence":"additional","affiliation":[]},{"given":"Paul J","family":"Christos","sequence":"additional","affiliation":[]},{"given":"Iman","family":"Osman","sequence":"additional","affiliation":[]},{"given":"Michelle","family":"Krogsgaard","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"342_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/CJI.0b013e3181e032e8","volume":"33","author":"DT Alexandrescu","year":"2010","unstructured":"Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Di Nardo A, Kabigting FD, Dasanu CA: Immunotherapy for melanoma: current status and perspectives. J Immunother. 2010, 33: 570-590. 10.1097\/CJI.0b013e3181e032e8.","journal-title":"J Immunother"},{"key":"342_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1089\/cbr.2008.0593","volume":"24","author":"D Loose","year":"2009","unstructured":"Loose D, Van de Wiele C: The immune system and cancer. Cancer Biother Radiopharm. 2009, 24: 369-376. 10.1089\/cbr.2008.0593.","journal-title":"Cancer Biother Radiopharm"},{"key":"342_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1600-065X.2008.00606.x","volume":"222","author":"AB Frey","year":"2008","unstructured":"Frey AB, Monu N: Signaling defects in anti-tumor T cells. Immunol Rev. 2008, 222: 192-205. 10.1111\/j.1600-065X.2008.00606.x.","journal-title":"Immunol Rev"},{"key":"342_CR4","volume-title":"Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking","author":"CA Galea","year":"2013","unstructured":"Galea CA, Nguyen HM, George Chandy K, Smith BJ, Norton RS: Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking. 2013, Cellular and molecular life sciences, CMLS"},{"key":"342_CR5","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.1021\/bi901656f","volume":"48","author":"GS Butler","year":"2009","unstructured":"Butler GS, Overall CM: Updated biological roles for matrix metalloproteinases and new \u201cintracellular\u201d substrates revealed by degradomics. Biochemistry. 2009, 48: 10830-10845. 10.1021\/bi901656f.","journal-title":"Biochemistry"},{"key":"342_CR6","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.ajpath.2012.08.044","volume":"181","author":"LA Shuman Moss","year":"2012","unstructured":"Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG: Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol. 2012, 181: 1895-1899. 10.1016\/j.ajpath.2012.08.044.","journal-title":"Am J Pathol"},{"key":"342_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1742-4658.2010.07920.x","volume":"278","author":"E Hadler-Olsen","year":"2011","unstructured":"Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO: Regulation of matrix metalloproteinase activity in health and disease. FEBS J. 2011, 278: 28-45. 10.1111\/j.1742-4658.2010.07920.x.","journal-title":"FEBS J"},{"key":"342_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mam.2011.10.015","volume":"33","author":"D Sbardella","year":"2012","unstructured":"Sbardella D, Fasciglione GF, Gioia M, Ciaccio C, Tundo GR, Marini S, Coletta M: Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Asp Med. 2012, 33: 119-208. 10.1016\/j.mam.2011.10.015.","journal-title":"Mol Asp Med"},{"key":"342_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1210\/mend.15.5.0638","volume":"15","author":"J Ohnishi","year":"2001","unstructured":"Ohnishi J, Ohnishi E, Jin M, Hirano W, Nakane D, Matsui H, Kimura A, Sawa H, Nakayama K, Shibuya H, Nagashima K, Takahashi T: Cloning and characterization of a rat ortholog of MMP-23 (matrix metalloproteinase-23), a unique type of membrane-anchored matrix metalloproteinase and conditioned switching of its expression during the ovarian follicular development. Mol Endocrinol. 2001, 15: 747-764. 10.1210\/mend.15.5.0638.","journal-title":"Mol Endocrinol"},{"key":"342_CR10","doi-asserted-by":"publisher","first-page":"33988","DOI":"10.1074\/jbc.M006493200","volume":"275","author":"D Pei","year":"2000","unstructured":"Pei D, Kang T, Qi H: Cysteine array matrix metalloproteinase (CA-MMP)\/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation. J Biol Chem. 2000, 275: 33988-33997. 10.1074\/jbc.M006493200.","journal-title":"J Biol Chem"},{"key":"342_CR11","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1074\/jbc.M112.421495","volume":"288","author":"HM Nguyen","year":"2013","unstructured":"Nguyen HM, Galea CA, Schmunk G, Smith BJ, Edwards RA, Norton RS, Chandy KG: Intracellular trafficking of the KV1.3 potassium channel is regulated by the prodomain of a matrix metalloprotease. J Biol Chem. 2013, 288: 6451-6464. 10.1074\/jbc.M112.421495.","journal-title":"J Biol Chem"},{"key":"342_CR12","doi-asserted-by":"publisher","first-page":"9124","DOI":"10.1074\/jbc.M109.071266","volume":"285","author":"S Rangaraju","year":"2010","unstructured":"Rangaraju S, Khoo KK, Feng ZP, Crossley G, Nugent D, Khaytin I, Chi V, Pham C, Calabresi P, Pennington MW, Norton RS, Chandy KG: Potassium channel modulation by a toxin domain in matrix metalloprotease 23. J Biol Chem. 2010, 285: 9124-9136. 10.1074\/jbc.M109.071266.","journal-title":"J Biol Chem"},{"key":"342_CR13","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","volume":"103","author":"C Beeton","year":"2006","unstructured":"Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, Wang PH, LeeHealey CJ BSA, Sankaranarayanan A, Homerick D, Roeck WW, Tehranzadeh J, Stanhope KL, Zimin P, Havel PJ, Griffey S, Knaus HG, Nepom GT, Gutman GA, Calabresi PA, Chandy KG: Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Nat Acad Sci USA. 2006, 103: 17414-17419. 10.1073\/pnas.0605136103.","journal-title":"Proc Nat Acad Sci USA"},{"key":"342_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1517\/14728220903018957","volume":"13","author":"S Rangaraju","year":"2009","unstructured":"Rangaraju S, Chi V, Pennington MW, Chandy KG: Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin Ther Targets. 2009, 13: 909-924. 10.1517\/14728220903018957.","journal-title":"Expert Opin Ther Targets"},{"key":"342_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1523-1747.2000.00068.x","volume":"115","author":"UB Hofmann","year":"2000","unstructured":"Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ: Matrix metalloproteinases in human melanoma. J Investigative Derm. 2000, 115: 337-344. 10.1046\/j.1523-1747.2000.00068.x.","journal-title":"J Investigative Derm"},{"key":"342_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2: 161-174. 10.1038\/nrc745.","journal-title":"Nat Rev Cancer"},{"key":"342_CR17","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2009.23.5556","volume":"27","author":"R Roy","year":"2009","unstructured":"Roy R, Yang J, Moses MA: Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009, 27: 5287-5297. 10.1200\/JCO.2009.23.5556.","journal-title":"J Clin Oncol"},{"key":"342_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, and cancer. Cell. 2010, 140: 883-899. 10.1016\/j.cell.2010.01.025.","journal-title":"Cell"},{"key":"342_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ccr.2011.01.037","volume":"19","author":"E Godefroy","year":"2011","unstructured":"Godefroy E, Manches O, Dreno B, Hochman T, Rolnitzky L, Labarriere N, Guilloux Y, Goldberg J, Jotereau F, Bhardwaj N: Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway. Cancer Cell. 2011, 19: 333-346. 10.1016\/j.ccr.2011.01.037.","journal-title":"Cancer Cell"},{"key":"342_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.lungcan.2009.12.007","volume":"69","author":"M Li","year":"2010","unstructured":"Li M, Xiao T, Zhang Y, Feng L, Lin D, Liu Y, Mao Y, Guo S, Han N, Di X, Zhang K, Cheng S, Gao Y: Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients. Lung Cancer. 2010, 69: 341-347. 10.1016\/j.lungcan.2009.12.007.","journal-title":"Lung Cancer"},{"key":"342_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3109\/07357901003735634","volume":"28","author":"Q Qian","year":"2010","unstructured":"Qian Q, Wang Q, Zhan P, Peng L, Wei SZ, Shi Y, Song Y: The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis. Cancer Investig. 2010, 28: 661-669. 10.3109\/07357901003735634.","journal-title":"Cancer Investig"},{"key":"342_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.lungcan.2007.07.005","volume":"58","author":"D Liu","year":"2007","unstructured":"Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Urushihara M, Huang CL: Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer. 2007, 58: 384-391. 10.1016\/j.lungcan.2007.07.005.","journal-title":"Lung Cancer"},{"key":"342_CR23","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/annonc\/mdn180","volume":"19","author":"PM McGowan","year":"2008","unstructured":"McGowan PM, Duffy MJ: Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. Ann Oncol. 2008, 19: 1566-1572. 10.1093\/annonc\/mdn180.","journal-title":"Ann Oncol"},{"key":"342_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2559.2007.02615.x","volume":"50","author":"E Mylona","year":"2007","unstructured":"Mylona E, Nomikos A, Magkou C, Kamberou M, Papassideri I, Keramopoulos A, Nakopoulou L: The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma. Histopathology. 2007, 50: 338-347. 10.1111\/j.1365-2559.2007.02615.x.","journal-title":"Histopathology"},{"key":"342_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/sj.bjc.6690763","volume":"81","author":"UB Hofmann","year":"1999","unstructured":"Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ, van Muijen GN: Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer. 1999, 81: 774-782. 10.1038\/sj.bjc.6690763.","journal-title":"Br J Cancer"},{"key":"342_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-2230.2005.01849.x","volume":"30","author":"P Redondo","year":"2005","unstructured":"Redondo P, Lloret P, Idoate M, Inoges S: Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression. Clin Exp Dermatol. 2005, 30: 541-545. 10.1111\/j.1365-2230.2005.01849.x.","journal-title":"Clin Exp Dermatol"},{"key":"342_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-4632.2012.05772.x","volume":"53","author":"E Candrea","year":"2014","unstructured":"Candrea E, Senila S, Tatomir C, Cosgarea R: Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma. Int J Dermatol. 2014, 53: 575-580. 10.1111\/j.1365-4632.2012.05772.x.","journal-title":"Int J Dermatol"},{"key":"342_CR28","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Fingleton B, Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002, 295: 2387-2392. 10.1126\/science.1067100.","journal-title":"Science"},{"key":"342_CR29","first-page":"35","volume":"1","author":"LG Wich","year":"2009","unstructured":"Wich LG, Hamilton HK, Shapiro RL, Pavlick A, Berman RS, Polsky D, Goldberg JD, Hernando E, Manga P, Krogsgaard M, Kamino H, Darvishian F, Lee P, Orlow SJ, Ostrer H, Bhardwaj N, Osman I: Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res. 2009, 1: 35-43.","journal-title":"Am J Transl Res"},{"key":"342_CR30","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","volume":"81","author":"WH Clark Jr","year":"1989","unstructured":"Clark WH, Elder DE, Guerry D, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC: Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989, 81: 1893-1904. 10.1093\/jnci\/81.24.1893.","journal-title":"J Natl Cancer Inst"},{"key":"342_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1085\/jgp.20028607","volume":"120","author":"VV Artym","year":"2002","unstructured":"Artym VV, Petty HR: Molecular proximity of Kv1.3 voltage-gated potassium channels and beta(1)-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J Gen Physiol. 2002, 120: 29-37. 10.1085\/jgp.20028607.","journal-title":"J Gen Physiol"},{"key":"342_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00232-006-0065-7","volume":"214","author":"M Abdul","year":"2006","unstructured":"Abdul M, Hoosein N: Reduced Kv1.3 potassium channel expression in human prostate cancer. J Membrane Biology. 2006, 214: 99-102. 10.1007\/s00232-006-0065-7.","journal-title":"J Membrane Biology"},{"key":"342_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.immuni.2008.07.015","volume":"29","author":"MP Matheu","year":"2008","unstructured":"Matheu MP, Beeton C, Garcia A, Chi V, Rangaraju S, Safrina O, Monaghan K, Uemura MI, Li D, Pal S, de la Maza LM, Monuki E, Flugel A, Pennington MW, Parker I, Chandy KG, Cahalan MD: Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity. 2008, 29: 602-614. 10.1016\/j.immuni.2008.07.015.","journal-title":"Immunity"},{"key":"342_CR34","first-page":"3","volume":"9","author":"DA Oble","year":"2009","unstructured":"Oble DA, Loewe R, Yu P, Mihm MC: Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun. 2009, 9: 3-","journal-title":"Cancer Immun"},{"key":"342_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/sj.jid.5701046","volume":"128","author":"G De Panfilis","year":"2008","unstructured":"De Panfilis G, Campanini N, Santini M, Mori G, Tognetti E, Maestri R, Lombardi M, Froio E, Ferrari D, Ricci R: Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma. J Investigative Derma. 2008, 128: 676-684.","journal-title":"J Investigative Derma"},{"key":"342_CR36","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/S1470-2045(11)70155-3","volume":"13","author":"JF Jacobs","year":"2012","unstructured":"Jacobs JF, Nierkens S, Figdor CG, de Vries IJ, Adema GJ: Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?. lancet Oncol. 2012, 13: e32-e42. 10.1016\/S1470-2045(11)70155-3.","journal-title":"lancet Oncol"},{"key":"342_CR37","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.4049\/jimmunol.0802982","volume":"182","author":"AG Sikora","year":"2009","unstructured":"Sikora AG, Jaffarzad N, Hailemichael Y, Gelbard A, Stonier SW, Schluns KS, Frasca L, Lou Y, Liu C, Andersson HA, Hwu P, Overwijk WW: IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity. J Immunol. 2009, 182: 7398-7407. 10.4049\/jimmunol.0802982.","journal-title":"J Immunol"},{"key":"342_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00262-006-0188-9","volume":"56","author":"MT Hueman","year":"2007","unstructured":"Hueman MT, Stojadinovic A, Storrer CE, Dehqanzada ZA, Gurney JM, Shriver CD, Ponniah S, Peoples GE: Analysis of naive and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2\/neu peptide (E75) and GM-CSF vaccine. Cancer Immun, Immunotherapy. 2007, 56: 135-146. 10.1007\/s00262-006-0188-9.","journal-title":"Cancer Immun, Immunotherapy"},{"key":"342_CR39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1462-5822.2011.01594.x","volume":"13","author":"NS Butler","year":"2011","unstructured":"Butler NS, Nolz JC, Harty JT: Immunologic considerations for generating memory CD8 T cells through vaccination. Cell Microbiol. 2011, 13: 925-933. 10.1111\/j.1462-5822.2011.01594.x.","journal-title":"Cell Microbiol"},{"key":"342_CR40","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1172\/JCI32446","volume":"117","author":"CH June","year":"2007","unstructured":"June CH: Adoptive T cell therapy for cancer in the clinic. J Clin Invest. 2007, 117: 1466-1476. 10.1172\/JCI32446.","journal-title":"J Clin Invest"},{"key":"342_CR41","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.4161\/cc.8.12.8745","volume":"8","author":"JR Brody","year":"2009","unstructured":"Brody JR, Costantino CL, Berger AC, Sato T, Lisanti MP, Yeo CJ, Emmons RV, Witkiewicz AK: Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival. Cell Cycle. 2009, 8: 1930-1934. 10.4161\/cc.8.12.8745.","journal-title":"Cell Cycle"},{"key":"342_CR42","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1600-0625.2011.01260.x","volume":"20","author":"AC Knol","year":"2011","unstructured":"Knol AC, Nguyen JM, Quereux G, Brocard A, Khammari A, Dreno B: Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma. Exp Dermatol. 2011, 20: 430-434. 10.1111\/j.1600-0625.2011.01260.x.","journal-title":"Exp Dermatol"},{"key":"342_CR43","first-page":"1115","volume":"18","author":"C Miracco","year":"2007","unstructured":"Miracco C, Mourmouras V, Biagioli M, Rubegni P, Mannucci S, Monciatti I, Cosci E, Tosi P, Luzi P: Utility of tumour-infiltrating CD25\u2009+\u2009FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Oncol Rep. 2007, 18: 1115-1122.","journal-title":"Oncol Rep"},{"key":"342_CR44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12253-010-9254-x","volume":"16","author":"A Ladanyi","year":"2010","unstructured":"Ladanyi A, Mohos A, Somlai B, Liszkay G, Gilde K, Fejos Z, Gaudi I, Timar J: FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma. Pathol Oncol Res. 2010, 16: 303-309. 10.1007\/s12253-010-9254-x.","journal-title":"Pathol Oncol Res"},{"key":"342_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00262-007-0353-9","volume":"57","author":"F Hillen","year":"2008","unstructured":"Hillen F, Baeten CI, van de Winkel A, Creytens D, van der Schaft DW, Winnepenninckx V, Griffioen AW: Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma. Cancer Immun, Immunotherapy. 2008, 57: 97-106. 10.1007\/s00262-007-0353-9.","journal-title":"Cancer Immun, Immunotherapy"},{"key":"342_CR46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1182\/blood-2006-01-0177","volume":"108","author":"S Wei","year":"2006","unstructured":"Wei S, Kryczek I, Zou W: Regulatory T-cell compartmentalization and trafficking. Blood. 2006, 108: 426-431. 10.1182\/blood-2006-01-0177.","journal-title":"Blood"},{"key":"342_CR47","first-page":"7","volume":"1806","author":"S Nizar","year":"2010","unstructured":"Nizar S, Meyer B, Galustian C, Kumar D, Dalgleish A: T regulatory cells, the evolution of targeted immunotherapy. Biochim Biophys Acta. 2010, 1806: 7-17.","journal-title":"Biochim Biophys Acta"},{"key":"342_CR48","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.4049\/jimmunol.1103095","volume":"188","author":"AR Gocke","year":"2012","unstructured":"Gocke AR, Lebson LA, Grishkan IV, Hu L, Nguyen HM, Whartenby KA, Chandy KG, Calabresi PA: Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. J Immunol. 2012, 188: 5877-5886. 10.4049\/jimmunol.1103095.","journal-title":"J Immunol"},{"key":"342_CR49","first-page":"3347","volume":"23","author":"M Abdul","year":"2003","unstructured":"Abdul M, Santo A, Hoosein N: Activity of potassium channel-blockers in breast cancer. Anticancer Res. 2003, 23: 3347-3351.","journal-title":"Anticancer Res"},{"key":"342_CR50","first-page":"961","volume":"9","author":"M Abdul","year":"2002","unstructured":"Abdul M, Hoosein N: Voltage-gated potassium ion channels in colon cancer. Oncol Rep. 2002, 9: 961-964.","journal-title":"Oncol Rep"},{"key":"342_CR51","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.4161\/cc.8.21.9888","volume":"8","author":"DJ Blackiston","year":"2009","unstructured":"Blackiston DJ, McLaughlin KA, Levin M: Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle. 2009, 8: 3519-3528. 10.4161\/cc.8.21.9888.","journal-title":"Cell Cycle"},{"key":"342_CR52","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1084\/jem.20082492","volume":"206","author":"KS Peggs","year":"2009","unstructured":"Peggs KS, Quezada SA, Chambers CA, Korman AJ, Allison JP: Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J Exp Med. 2009, 206: 1717-1725. 10.1084\/jem.20082492.","journal-title":"J Exp Med"},{"key":"342_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/CCO.0b013e3283436e79","volume":"23","author":"J Weber","year":"2011","unstructured":"Weber J: Immunotherapy for melanoma. Curr Opin Oncol. 2011, 23: 163-169. 10.1097\/CCO.0b013e3283436e79.","journal-title":"Curr Opin Oncol"},{"key":"342_CR54","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.1074\/jbc.274.8.4570","volume":"274","author":"G Velasco","year":"1999","unstructured":"Velasco G, Pendas AM, Fueyo A, Knauper V, Murphy G, Lopez-Otin C: Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem. 1999, 274: 4570-4576. 10.1074\/jbc.274.8.4570.","journal-title":"J Biol Chem"},{"key":"342_CR55","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbe C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010, 363: 711-723. 10.1056\/NEJMoa1003466.","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"342_CR56","first-page":"S1","volume":"7","author":"DC Allred","year":"2009","unstructured":"Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC: NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. JNCCN. 2009, 7 (Suppl 6): S1-S21. quiz S22-23","journal-title":"JNCCN"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0342-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-014-0342-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0342-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-014-0342-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:53:35Z","timestamp":1630565615000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-014-0342-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1186\/s12967-014-0342-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"24 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"342"}}